Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Bone Growth Stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures/fusions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone growth stimulators devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the bone growth stimulators market in Australia was Orthofix Holdings Inc followed by DJO Global, ZimVie and Bioventus.
Bone Growth Stimulators apply electrical or ultrasound waves to the site of the fracture/fusion. The usage of the stimulators for the following bones are tracked here: radius, ulna, tibia, fibula, clavicle, scapula, humerus and femur. Bone Growth Stimulators can be either External or Implantable Devices. External Bone Growth Stimulators are the stimulation devices which are worn outside the skin and do not require any surgical intervention. Implantable Bone Growth Stimulators are the stimulation devices which are implanted during surgery to stabilize the fracture.
The value of the bone growth stimulators devices market within Australia was expected to be over $10m in 2023.
For the latest complete market share analysis of bone growth stimulators device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
